QR koda

Current insights into monitoring of congenital adrenal hyperplasia

The management of 21-hydroxylase deficiency (21OHD), the most common form of congenital adrenal hyperplasia, remains challenging as both over- and undertreatment with hormone replacement therapy are associated with short and long-term complications. Monitoring of treatment efficacy typically combine...

Popoln opis

Shranjeno v:
Principais autores: Quinty M. Leusink, Elke E. W. Verploegen, Bas P. H. Adriaansen, Xinyi Chin, Nike M. M. L. Stikkelbroeck, Paul N. Span, Fred C. G. J. Sweep, Margo Dona, Antonius E. van Herwaarden, Hedi L. Claahsen-van der Grinten
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2026-02-01
Serija:Frontiers in Endocrinology
Teme:
congenital adrenal hyperplasia (CAH)
21-hydroxylase deficiency (21OHD)
monitoring
biomarkers
reference intervals
Online dostop:https://www.frontiersin.org/articles/10.3389/fendo.2026.1774145/full
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki